Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 213,192 | 133,265 | 152,645 | 5,614 | 34,766 |
| Receivables | 18,000 | N/A | N/A | N/A | N/A |
| TOTAL | $236,655 | $134,563 | $154,227 | $5,992 | $34,804 |
| Non-Current Assets | |||||
| PPE Net | 846 | 782 | 193 | N/A | N/A |
| Other Non-Current Assets | 2,792 | 2,924 | 3,013 | 0 | 813 |
| TOTAL | $3,638 | $3,706 | $3,206 | $N/A | $813 |
| Total Assets | $240,293 | $138,269 | $157,433 | $5,992 | $35,617 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,137 | 8,834 | 6,831 | 105 | 7,328 |
| Accrued Expenses | 16,344 | 8,965 | 7,608 | 2,512 | 2,225 |
| Other current liabilities | 5,000 | 2,088 | 2,096 | N/A | 61 |
| TOTAL | $36,072 | $20,304 | $16,746 | $2,617 | $9,614 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | N/A | N/A | 37,482 |
| Deferred Revenues | 4,156 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,209 | 1,324 | 1,433 | 0 | 4,000 |
| TOTAL | $1,209 | $1,324 | $1,433 | $N/A | $41,482 |
| Total Liabilities | $37,281 | $21,628 | $18,179 | $2,617 | $51,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,557 | 13,893 | 13,893 | 645 | 645 |
| Common Shares | 28 | 14 | 14 | 65 | 1 |
| Retained earnings | -171,809 | -79,412 | -54,805 | -496,708 | -17,867 |
| Other shareholders' equity | 4,000 | 4,000 | 4,000 | 0 | 0 |
| TOTAL | $203,012 | $116,641 | $139,254 | $3,375 | $-15,479 |
| Total Liabilities And Equity | $240,293 | $138,269 | $157,433 | $5,992 | $35,617 |